'''Desoxypipradrol''', also known as '''2-diphenylmethylpiperidine''' ('''2-DPMP'''), acts as a [[norepinephrine-dopamine reuptake inhibitor]] (NDRI)<ref name="Ferris RM 1979">{{cite journal | last1 = Ferris | first1 = RM | last2 = Tang | first2 = FL | title = Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-3Hnorepinephrine and 3Hdopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 210 | issue = 3 | pages = 422â€“8 | year = 1979 | pmid = 39160}}</ref> developed by Ciba in the 1950s.<ref>US Patent 2820038 - 2-Diphenyl-Methyl-Piperidine</ref>
